143 related articles for article (PubMed ID: 35590116)
1. Endometrioid Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Managements.
Ricotta G; Maulard A; Candiani M; Scherrier S; Genestie C; Pautier P; Leary A; Chargari C; Mangili G; Morice P; Gouy S
Ann Surg Oncol; 2022 Sep; 29(9):5894-5903. PubMed ID: 35590116
[TBL] [Abstract][Full Text] [Related]
2. Clear Cell Borderline Ovarian Tumor: Clinical Characteristics, Prognosis, and Management.
Ricotta G; Maulard A; Candiani M; Genestie C; Pautier P; Leary A; Chargari C; Mangili G; Morice P; Gouy S
Ann Surg Oncol; 2022 Feb; 29(2):1165-1170. PubMed ID: 34596794
[TBL] [Abstract][Full Text] [Related]
3. Management and prognosis of endometrioid borderline tumors of the ovary.
Uzan C; Berretta R; Rolla M; Gouy S; Fauvet R; Darai E; Duvillard P; Morice P
Surg Oncol; 2012 Sep; 21(3):178-84. PubMed ID: 22418038
[TBL] [Abstract][Full Text] [Related]
4. Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary.
Jia SZ; Zhang JJ; Yang JJ; Xiang Y; Liang Z; Leng JH
J Ovarian Res; 2018 Apr; 11(1):30. PubMed ID: 29673382
[TBL] [Abstract][Full Text] [Related]
5. Brenner Borderline Ovarian Tumor: A Case Series and Literature Review.
Ricotta G; Maulard A; Genestie C; Pautier P; Leary A; Chargari C; Candiani M; Morice P; Gouy S
Ann Surg Oncol; 2021 Oct; 28(11):6714-6720. PubMed ID: 33768396
[TBL] [Abstract][Full Text] [Related]
6. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of endometrioid borderline ovarian tumor with and without endometriosis.
Zhang W; Jia S; Xiang Y; Yang J; Jia C; Leng J
J Ovarian Res; 2018 Aug; 11(1):67. PubMed ID: 30098603
[TBL] [Abstract][Full Text] [Related]
8. Ovarian intestinal type mucinous borderline tumors: are we ready for a nomenclature change?
Chiesa AG; Deavers MT; Veras E; Silva EG; Gershenson D; Malpica A
Int J Gynecol Pathol; 2010 Mar; 29(2):108-12. PubMed ID: 20173495
[TBL] [Abstract][Full Text] [Related]
9. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Canlorbe G; Lecointre L; Chauvet P; Azaïs H; Fauvet R; Uzan C
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):287-303. PubMed ID: 32004786
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
11. Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility.
Wang P; Fang L
World J Surg Oncol; 2021 Apr; 19(1):132. PubMed ID: 33882931
[TBL] [Abstract][Full Text] [Related]
12. Management and prognosis of clear cell borderline ovarian tumor.
Uzan C; Dufeu-Lefebvre M; Fauvet R; Gouy S; Duvillard P; Darai E; Morice P
Int J Gynecol Cancer; 2012 Jul; 22(6):993-9. PubMed ID: 22622950
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
[No Abstract] [Full Text] [Related]
14. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
15. Management and prognosis of borderline ovarian Brenner tumors.
Uzan C; Dufeu-Lefebvre M; Fauvet R; Gouy S; Duvillard P; Darai E; Morice P
Int J Gynecol Cancer; 2012 Oct; 22(8):1332-6. PubMed ID: 22954784
[TBL] [Abstract][Full Text] [Related]
16. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of microinvasion in borderline ovarian tumors and its impact on surgical management.
Ferrero A; Strada I; Di Marcoberardino B; Maccarini LR; Pozzati F; Rossi M; Biglia N; De Iaco P
Int J Gynecol Cancer; 2012 Sep; 22(7):1158-62. PubMed ID: 22801031
[TBL] [Abstract][Full Text] [Related]
18. Ovarian tumors of borderline malignancy: a review of 247 patients from 1991 to 2004.
Wong HF; Low JJ; Chua Y; Busmanis I; Tay EH; Ho TH
Int J Gynecol Cancer; 2007; 17(2):342-9. PubMed ID: 17343573
[TBL] [Abstract][Full Text] [Related]
19. Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Ann Surg Oncol; 2008 Dec; 15(12):3561-6. PubMed ID: 18820973
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.
Uzan C; Muller E; Kane A; Rey A; Gouy S; Bendiffallah S; Duvillard P; Fauvet R; Darai E; Morice P
Ann Oncol; 2014 Jan; 25(1):166-71. PubMed ID: 24287939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
